Stool Softener Market Report 2026

Stool Softener Market Overview

• Stool Softener market size has reached to $1.81 billion in 2025 • Expected to grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 6.6% • Growth Driver: Gastrointestinal Disorder Trends Fueling the Expansion Of The Stool Softener Market • Market Trend: Innovative Ayurvedic Solutions For Natural Constipation Relief • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Stool Softener Market?

A stool softener is a type of laxative that helps soften stool by increasing the amount of water in the intestines, making it easier to pass without straining. It is used for treating mild constipation and is often recommended for people who should avoid straining during bowel movements, such as after surgery. Stool softeners are used short-term to relieve occasional constipation and are available over-the-counter (OTC) or by prescription. The main types of stool softeners are liquid and softgel capsules. Liquid refers to a type of stool softener product that is available in a liquid form, which can be taken orally or used rectally to help soften and ease bowel movements. The forms of stool softener are medicines and procedures, and the modes of administration are oral and rectal. The availability of stool softener is over-the-counter and prescription, and it is used by various end users, such as hospitals, clinics, home care, and others.

What Is The Stool Softener Market Growth Forecast?

The stool softener market size is expected to see strong growth in the next few years. It will grow to $2.51 billion in 2030 at a compound annual growth rate (CAGR) of 6.6%. The growth in the forecast period can be attributed to rising geriatric population, growth in home healthcare, demand for gentle laxatives, increased awareness of digestive health, expanding retail pharmacy networks. Major trends in the forecast period include plant-based formulations, sugar-free laxatives, flavored oral dosage forms, combination stool softeners, pediatric-friendly products.

Global Stool Softener Market Segmentation

1) By Type: Liquid, Softgel Capsule 2) By Form: Medicines, Prescription Products 3) By Mode Of Administration: Oral, Rectal 4) By Availability: Over-The-Counter, Prescription 5) By End Use: Hospitals, Clinics, Home Care, Other End Uses Subsegments: 1) By Liquid: Oral Solutions, Syrups, Drops 2) By Softgel Capsule: Standard Softgel Capsules, Enhanced Or High-Dosage Softgel Capsules

What Is The Driver Of The Stool Softener Market?

The increasing prevalence of gastrointestinal disorders is expected to propel the growth of the stool softener market going forward. Gastrointestinal disorders refer to any condition or disease that affects the gastrointestinal tract, which includes the mouth, esophagus, stomach, small intestine, large intestine, and anus. The increasing prevalence of gastrointestinal disorders is attributed to various factors, including lifestyle changes such as poor diet, lack of exercise, and stress. Stool softeners help alleviate gastrointestinal disorders by making stools easier to pass, thereby preventing constipation and reducing strain during bowel movements. For instance, in 2023, according to Crohn's and Colitis Canada, a Canada-based non-profit organization, the number of people in Canada with IBD is increasing rapidly, from 322,600 in 2023 (0.8% of the population) to 470,000 in 2035 (1.1% of the population). In 2023, 11,000 people will be diagnosed (1 every 48 minutes), and by 2035, this will rise to 14,000 (1 every 38 minutes). Therefore, the increasing prevalence of gastrointestinal disorders is driving the growth of the stool softener industry.

Key Players In The Global Stool Softener Market

Major companies operating in the stool softener market are F. Hoffmann-La Roche Ltd., Bayer AG, AstraZeneca Plc., Abbott Laboratories Inc., Takeda Pharmaceutical Company Ltd., GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Solvay S.A., Teva Pharmaceutical Industries Ltd., Mylan N.V., Purdue Pharma L.P., Mallinckrodt Plc, Aristo Pharma GmbH, Raptakos Brett Co. Ltd., Unipex Group Inc., Chemo Biological, Angiolife Healthcare Pvt. Ltd., Iscon Life Sciences, Starmed Pvt. Ltd., Phaedrus Ltd., Stadmed Pvt. Ltd., Avrio Health L.P., Healwell, Velnex Medicare, Sanify Healthcare Pvt. Ltd.

Global Stool Softener Market Trends and Insights

Major companies operating in the stool softener market are focusing on developing innovative products such as ayurvedic liquid laxative to provide natural and gentle relief options for consumers. An Ayurvedic liquid laxative is a natural, herbal-based formulation designed to relieve constipation by promoting gentle bowel movements. It combines traditional Ayurvedic ingredients known for their digestive benefits to support overall gut health. For instance, in December 2023, Lupin Limited, an India-based pharmaceutical company launched Softovac Liquifibre. This product is a 100% ayurvedic liquid laxative that combines Isabgol fiber with natural ingredients such as Sonamukhi and Harad, providing effective relief from constipation. This product is clinically validated for safety and efficacy, ensuring it is gentle, non-habit-forming, and suitable for daily use, even for diabetics due to its sugar-free formulation.

What Are Latest Mergers And Acquisitions In The Stool Softener Market?

In June 2023, Atlantis Consumer Healthcare Inc., a US-based pharmaceutical company, acquired Colace, Senokot, Betadine, and SlowMag brands from Avrio Health L.P. (Avrio) for an undisclosed amount. This acquisition will further distinguish Arcadia as a leader in health and wellness and allow the company to enhance the well-being of more consumers. Avrio Health L.P. is a US-based company that provides stool softeners.

Regional Outlook

North America was the largest region in the stool softener market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Stool Softener Market?

The stool softener market consists of sales of docusate sodium, docusate calcium, liquid gels, and fiber supplements. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Stool Softener Market Report 2026?

The stool softener market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the stool softener industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.